Dan Pu

机构：Sichuan University, West China Hospital of Sichuan University · ORCID：0000-0001-6628-9714

发表论文 47 篇 · 总被引 500 次 · h-index 10

代表论文

• Safety and efficacy of immune checkpoint inhibitors in patients with HBV/HCV infection and advanced-stage cancer (2020 · Medicine · 被引 85)
• Celastrol Exerts Cardioprotective Effect in Rheumatoid Arthritis by Inhibiting TLR2/HMGB1 Signaling Pathway-Mediated Autophagy (2021 · International Archives of Allergy and Immunology · 被引 22)
• Clinical features and prognostic factors of combined small cell lung cancer: development and validation of a nomogram based on the SEER database (2021 · Translational Lung Cancer Research · 被引 19)
• Molecular regulatory network of PD-1/PD-L1 in non-small cell lung cancer (2020 · Pathology - Research and Practice · 被引 15)
• Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia (2024 · Clinical Rheumatology · 被引 14)
• Tumor vessel normalization and immunotherapy in gastric cancer (2022 · Therapeutic Advances in Medical Oncology · 被引 13)